Literature DB >> 16355578

[Thyrotoxicosis following the use of ashwagandha].

C S van der Hooft1, A Hoekstra, A Winter, P A G de Smet, B H Ch Stricker.   

Abstract

A 32-year-old healthy woman developed thyrotoxicosis while taking capsules that contained ashwagandha herbal extract for symptoms of chronic fatigue. She was not taking any other remedies or medications. During the first few weeks, she took the capsules only occasionally without any symptoms, but after increasing the dose, she experienced clinical symptoms indicative of thyrotoxicosis. This was confirmed by laboratory assessment. The symptoms resolved spontaneously after discontinuation of the ashwagandha capsules and laboratory values normalised. To our knowledge, this relationship has not been reported previously in humans. Data from animal studies, however, have suggested that ashwagandha can increase serum concentrations of thyroid hormones. This case study suggests that thyrotoxicosis is a potentially serious side effect of ashwagandha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355578

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder.

Authors:  Jessica M Gannon; Paige E Forrest; K N Roy Chengappa
Journal:  J Ayurveda Integr Med       Date:  2014 Oct-Dec

Review 2.  Professional ethics in complementary and alternative medicines in management of Parkinson's disease.

Authors:  Hee Jin Kim; Beomseok Jeon; Sun Ju Chung
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

3.  Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia.

Authors:  Hawra I Kamal; Kunjal Patel; Alexandra Brdak; Jeremy Heffernan; Naseer Ahmad
Journal:  Cureus       Date:  2022-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.